Signum Biosciences

0 followers


Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.

Industries

+1

Headquarters

Stage

Employees

Links

Org chart

Maxwell Stock
CEO & Founder

Maxwell Stock

Collapse
Eduardo Perez
Chief Scientific Officer
Lisa Johnson
SVP of Global Sales & Corporate Development
Masanori (Markie) Tamura
Vice President of Product Development
Michael J. Losch
Chief Financial Officer